News Releases Year: All News2020201920182017201620152014201320122011 Items per page All News2550 September 8, 2020 Summary ToggleAllena Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial of ALLN-346, in Development for the Treatment of Hyperuricemia in Patients with Gout and Advanced Chronic Kidney Disease Read more September 3, 2020 Summary ToggleAllena Pharmaceuticals to Present Virtually at Upcoming Investor Conferences in September Read more August 5, 2020 Summary ToggleAllena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update Read more August 4, 2020 Summary ToggleAllena Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference Read more July 27, 2020 Summary ToggleAllena Pharmaceuticals Increases Previously Announced Bought Deal to $6.7 Million Read more July 27, 2020 Summary ToggleAllena Pharmaceuticals Announces $5.0 Million Bought Deal Offering Read more June 3, 2020 Summary ToggleAllena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Read more May 26, 2020 Summary ToggleAllena Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference Read more May 13, 2020 Summary ToggleAllena Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update Read more March 16, 2020 Summary ToggleAllena Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Provides Business Update Read more Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
